No Data
No Data
Internal Diagnostics' Set for Upside to Returns Post Merger With Capitol Health, Jarden Says
Jarden Sticks to Its Buy Rating for Integral Diagnostics Ltd. (IDX)
Jarden Adjusts Integral Diagnostics' Price Target to AU$3.68 From AU$3.72, Keeps at Buy
ACCC Conditionally Clears Integral Diagnostics' Proposed Acquisition of Capitol Health
Integral Expects to Complete Acquisition on December 20
Integral Diagnostics Will Divest a Capitol Radiology Clinic in Victoria State